Entero Healthcare Solutions (NSE:ENTERO) Notes Receivable: ₹0 Mil (As of Mar. 2026)


NSE:ENTERO Entero Healthcare Solutions Ltd NSE:ENTERO
52 GF Score
Price ₹1,210.90
! 2 Warning Signs
View Full Analysis

What is Entero Healthcare Solutions Notes Receivable?

Entero Healthcare Solutions NSE:ENTERO -0.45% 52 Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:ENTERO with a GF Score™ of 52/100. The stock has 2 warning signs investors should review.

Entero Healthcare Solutions's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0 Mil.

Entero Healthcare Solutions Notes Receivable Related Terms

Entero Healthcare Solutions Notes Receivable Historical Data

* Premium members only.

The historical data trend for Entero Healthcare Solutions's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entero Healthcare Solutions Notes Receivable Chart

Entero Healthcare Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Entero Healthcare Solutions Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:ENTERO
52GF Score
Entero Healthcare Solutions Ltd NSE:ENTERO
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Entero Healthcare Solutions Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0 Mil mean?
Entero Healthcare Solutions (NSE:ENTERO) has a Notes Receivable of ₹0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Entero Healthcare Solutions and its competitors.
Is Entero Healthcare Solutions' Notes Receivable too high?
Entero Healthcare Solutions' current Notes Receivable is ₹0 Mil. Overall, Entero Healthcare Solutions has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' Notes Receivable compare to MCK and CAH?
Entero Healthcare Solutions' Notes Receivable of ₹0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Distribution company?
A good Notes Receivable depends on the Medical Distribution industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Entero Healthcare Solutions and its competitors. Entero Healthcare Solutions's current Notes Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Entero Healthcare Solutions (NSE:ENTERO) has a current Notes Receivable of ₹0 Mil. The current Notes Receivable is ₹0 Mil. Entero Healthcare Solutions' overall GF Score™ is 52/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entero Healthcare Solutions Business Description

Other Exchanges 544122:India
Address Bandra Kurla Complex, Trade Centre, Unit No. 605 & 606, 6th Floor, Bandra East, Mumbai, MH, IND, 400051
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
52GF Score

Get the complete analysis for NSE:ENTERO

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,210.90
Price